TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription
TCF19 promotes glioma cell multiplication and cell-cycle transition while suppressing apoptosis by modulating the β-catenin signaling pathway via accelerating DHX32 transcription. These findings provide a promising therapeutic target for glioma.
Authors
- He-Yuan Lian
- Jing Ying Tan (ORCID: https://orcid.org/0000-0002-4605-4624)
- Tuo Wang (ORCID: https://orcid.org/0000-0002-9862-5038)
- Qi Zheng (ORCID: https://orcid.org/0000-0003-4654-2801)
- Tingting Yang (ORCID: https://orcid.org/0000-0002-9730-4566)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2025-01-22
- DOI
- https://doi.org/10.2174/0115680096360071241215171342
- Citations
- 2
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 2.09